Ballast Inc’s Amgen AMGN Stock Holding History

Ballast Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,380	Closed	-$286K	–	84
2018 Q3	$286K	Buy	+1,380	New	+$272K	0.2%	75

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ballast Inc's AMGN Position: Q4 2018 in Review

Ballast Inc sold out of Amgen (AMGN) in Q4 2018, closing a stake of 1,380 shares — an estimated $286K sold.

Ballast Inc first reported a position in AMGN in Q3 2018 and held it in 1 quarter. The position peaked at $286K in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

Ballast Inc reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
Ballast Inc sold 1,380 Amgen shares in Q4 2018, an estimated $286K.
Ballast Inc first reported a position in Amgen in Q3 2018 and held it in 1 quarter.
Ballast Inc's Amgen position peaked at $286K in Q3 2018.
1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Ballast Inc's 13F filing for Q4 2018, filed 1 Feb 2019.